Anivance AI
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Digital health
Anivance AI delivers the fastest end-to-end organ-on-chip solution by combining rapid human organ model creation, accelerated phenotypic toxicity analysis, and automated AI-driven workflows. Our platform enables disease modeling within hours, detects cellular toxicity early through high-throughput imaging, and streamlines regulatory reporting. All of this is fully aligned with the U.S. FDA’s 2025 NAMs strategy for non-animal, human-relevant drug development.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}